|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Case reports |
a Department of Thoracic Surgery, University Hospital, Strasbourg, France
b Department of Thoracic Surgery, Georges Pompidou European Hospital, Paris, France
Received 4 September 2008; received in revised form 30 October 2008; accepted 7 November 2008.
* Corresponding author. Address: Department of Thoracic Surgery, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, 1 place de lHôpital, BP 426, 67091 Strasbourg Cedex, France. Tel.: +33 3 69551134; fax: +33 3 69551895. (Email: pierre-emmanuel.falcoz{at}wanadoo.fr).
Second primary non-small cell lung cancer (NSCLC) is a well-known disease in patients having undergone successful NSCLC resection. Surgery for patients with cancer in the residual lung after pneumonectomy should not be excluded automatically. However, surgery on a single residual lung is usually done by wedge resection or segmentectomy, whereas lobectomy remains somewhat exceptional. We report the cases of two right upper lobectomy patients, alive and doing well at 5- and 6-year follow-up, with a FEV1 equal to 36% and 35% of predicted value, respectively.
Key Words: Non-small cell lung cancer Lobectomy Metachronous lung cancer Single residual lung
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |